Published in Neurobiol Aging on May 05, 2010
7,8-dihydroxyflavone, a small-molecule TrkB agonist, reverses memory deficits and BACE1 elevation in a mouse model of Alzheimer's disease. Neuropsychopharmacology (2011) 1.40
Impairment of select forms of spatial memory and neurotrophin-dependent synaptic plasticity by deletion of glial aquaporin-4. J Neurosci (2011) 1.17
A touch screen-automated cognitive test battery reveals impaired attention, memory abnormalities, and increased response inhibition in the TgCRND8 mouse model of Alzheimer's disease. Neurobiol Aging (2012) 0.97
Hippocampal output area CA1 broadcasts a generalized novelty signal during an object-place recognition task. Hippocampus (2014) 0.95
False recognition in a mouse model of Alzheimer's disease: rescue with sensory restriction and memantine. Brain (2012) 0.89
The polyphenol oleuropein aglycone protects TgCRND8 mice against Aß plaque pathology. PLoS One (2013) 0.87
Entorhinal cortical defects in Tg2576 mice are present as early as 2-4 months of age. Neurobiol Aging (2014) 0.85
Experimental Malaria in Pregnancy Induces Neurocognitive Injury in Uninfected Offspring via a C5a-C5a Receptor Dependent Pathway. PLoS Pathog (2015) 0.84
PPARγ agonists improve survival and neurocognitive outcomes in experimental cerebral malaria and induce neuroprotective pathways in human malaria. PLoS Pathog (2014) 0.82
Hippocampal oscillatory activity in Alzheimer's disease: toward the identification of early biomarkers? Aging Dis (2013) 0.81
The entorhinal cortex and neurotrophin signaling in Alzheimer's disease and other disorders. Cogn Neurosci (2013) 0.81
Rapamycin and interleukin-1β impair brain-derived neurotrophic factor-dependent neuron survival by modulating autophagy. J Biol Chem (2014) 0.80
Early onset of hypersynchronous network activity and expression of a marker of chronic seizures in the Tg2576 mouse model of Alzheimer's disease. PLoS One (2015) 0.80
Reduced tissue levels of noradrenaline are associated with behavioral phenotypes of the TgCRND8 mouse model of Alzheimer's disease. Neuropsychopharmacology (2012) 0.80
Impaired Cholinergic Excitation of Prefrontal Attention Circuitry in the TgCRND8 Model of Alzheimer's Disease. J Neurosci (2015) 0.78
The Role of Astrocytic Aquaporin-4 in Synaptic Plasticity and Learning and Memory. Front Integr Neurosci (2016) 0.78
Oridonin Attenuates Synaptic Loss and Cognitive Deficits in an Aβ1-42-Induced Mouse Model of Alzheimer's Disease. PLoS One (2016) 0.77
Tumor Necrosis Factor-α Underlies Loss of Cortical Dendritic Spine Density in a Mouse Model of Congestive Heart Failure. J Am Heart Assoc (2015) 0.76
Phenotypic Alterations in Hippocampal NPY- and PV-Expressing Interneurons in a Presymptomatic Transgenic Mouse Model of Alzheimer's Disease. Front Aging Neurosci (2017) 0.75
Effects of Neurotrophic Support and Amyloid-Targeted Combined Therapy on Adult Hippocampal Neurogenesis in a Transgenic Model of Alzheimer's Disease. PLoS One (2016) 0.75
Differential contribution of APP metabolites to early cognitive deficits in a TgCRND8 mouse model of Alzheimer's disease. Sci Adv (2017) 0.75
Tau downregulates BDNF expression in animal and cellular models of Alzheimer's disease. Neurobiol Aging (2016) 0.75
Entorhinal Cortical Deep-Brain Stimulation Rescues Memory Deficits In Both Young And Old Mice Genetically Engineered To Model Alzheimer's Disease. Neuropsychopharmacology (2017) 0.75
Cognitive impairment and gene expression alterations in a rodent model of binge eating disorder. Physiol Behav (2017) 0.75
The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science (2002) 49.51
Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (1991) 49.03
Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol (1991) 14.25
A new one-trial test for neurobiological studies of memory in rats. 1: Behavioral data. Behav Brain Res (1988) 7.29
A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease. Nature (2001) 6.78
Rapid quantification of adult and developing mouse spatial vision using a virtual optomotor system. Invest Ophthalmol Vis Sci (2004) 4.56
Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695. J Biol Chem (2001) 4.51
The relationship between Abeta and memory in the Tg2576 mouse model of Alzheimer's disease. J Neurosci (2002) 4.27
Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease. Nat Med (2009) 4.11
Spatial memory, recognition memory, and the hippocampus. Proc Natl Acad Sci U S A (2004) 3.82
Identification of normal and pathological aging in prospectively studied nondemented elderly humans. Neurobiol Aging (1992) 3.05
Hippocampus-specific deletion of BDNF in adult mice impairs spatial memory and extinction of aversive memories. Mol Psychiatry (2007) 2.84
Regional distribution of brain-derived neurotrophic factor mRNA in the adult mouse brain. EMBO J (1990) 2.77
Double dissociation between the effects of peri-postrhinal cortex and hippocampal lesions on tests of object recognition and spatial memory: heterogeneity of function within the temporal lobe. J Neurosci (2004) 2.76
The pharmacology, neuroanatomy and neurogenetics of one-trial object recognition in rodents. Neurosci Biobehav Rev (2007) 2.68
Early diagnosis of Alzheimer's disease: contribution of structural neuroimaging. Neuroimage (2003) 2.52
On the delay-dependent involvement of the hippocampus in object recognition memory. Neurobiol Learn Mem (2004) 2.37
Precursor form of brain-derived neurotrophic factor and mature brain-derived neurotrophic factor are decreased in the pre-clinical stages of Alzheimer's disease. J Neurochem (2005) 2.36
Rhinal cortex lesions and object recognition in rats. Behav Neurosci (1994) 1.87
Stage-dependent BDNF serum concentrations in Alzheimer's disease. J Neural Transm (Vienna) (2005) 1.85
Effects of stress and hippocampal NMDA receptor antagonism on recognition memory in rats. Learn Mem (2002) 1.85
Expression of brain-derived neurotrophic factor protein in the adult rat central nervous system. Neuroscience (1997) 1.84
Corticohippocampal contributions to spatial and contextual learning. J Neurosci (2004) 1.80
Abeta(1-42) injection causes memory impairment, lowered cortical and serum BDNF levels, and decreased hippocampal 5-HT(2A) levels. Exp Neurol (2007) 1.58
The development of amyloid beta protein deposits in the aged brain. Sci Aging Knowledge Environ (2006) 1.55
Beta-amyloid peptide at sublethal concentrations downregulates brain-derived neurotrophic factor functions in cultured cortical neurons. J Neurosci (2004) 1.54
Alzheimer-like neurodegeneration in aged antinerve growth factor transgenic mice. Proc Natl Acad Sci U S A (2000) 1.47
Beta -amyloid-(1-42) impairs activity-dependent cAMP-response element-binding protein signaling in neurons at concentrations in which cell survival Is not compromised. J Biol Chem (2001) 1.43
Age-dependent cognitive decline in the APP23 model precedes amyloid deposition. Eur J Neurosci (2003) 1.36
Oligomeric amyloid decreases basal levels of brain-derived neurotrophic factor (BDNF) mRNA via specific downregulation of BDNF transcripts IV and V in differentiated human neuroblastoma cells. J Neurosci (2007) 1.30
Differential regulation of mRNAs for nerve growth factor, brain-derived neurotrophic factor, and neurotrophin 3 in the adult rat brain following cerebral ischemia and hypoglycemic coma. Proc Natl Acad Sci U S A (1992) 1.29
Does my mouse have Alzheimer's disease? Genes Brain Behav (2002) 1.28
Performance of different mouse strains in an object recognition task. Behav Brain Res (2003) 1.27
Recognition memory in rats--II. Neuroanatomical substrates. Prog Neurobiol (1998) 1.24
Object recognition analysis in mice using nose-point digital video tracking. J Neurosci Methods (2007) 1.22
Decreased brain-derived neurotrophic factor depends on amyloid aggregation state in transgenic mouse models of Alzheimer's disease. J Neurosci (2009) 1.19
Scopolamine-induced deficits in a two-trial object recognition task in mice. Neuroreport (1997) 1.15
Age-progressing cognitive impairments and neuropathology in transgenic CRND8 mice. Behav Brain Res (2005) 1.11
Cholinergic dysfunction, neuronal damage and axonal loss in TgCRND8 mice. Neurobiol Dis (2006) 1.10
Effects of voluntary and forced exercise on plaque deposition, hippocampal volume, and behavior in the Tg2576 mouse model of Alzheimer's disease. Neurobiol Dis (2009) 1.08
Alzheimer's disease: intraneuronal alterations precede insoluble amyloid-beta formation. Neurobiol Aging (2004) 1.06
Cognitive impact of neuronal pathology in the entorhinal cortex and CA1 field in Alzheimer's disease. Neurobiol Aging (2005) 1.02
Optokinetic test to evaluate visual acuity of each eye independently. J Neurosci Methods (2004) 1.02
Induction of brain-derived neurotrophic factor in plaque-associated glial cells of aged APP23 transgenic mice. J Neurosci (2004) 0.97
Cooperation between the hippocampus and the entorhinal cortex in spatial memory: a disconnection study. Behav Brain Res (2006) 0.93
Abnormal processing of tau in the brain of aged TgCRND8 mice. Neurobiol Dis (2007) 0.92
Activity changes and marked stereotypic behavior precede Abeta pathology in TgCRND8 Alzheimer mice. Neurobiol Aging (2005) 0.91
Beta-amyloid pathology in the entorhinal cortex of rats induces memory deficits: implications for Alzheimer's disease. Neuroscience (2007) 0.91
Effects of acute and subchronic administration of dexefaroxan, an alpha(2)-adrenoceptor antagonist, on memory performance in young adult and aged rodents. J Pharmacol Exp Ther (2002) 0.87
High intracellular concentrations of amyloid-beta block nuclear translocation of phosphorylated CREB. J Neurochem (2007) 0.87
Amyloid beta and impairment in multiple memory systems in older transgenic APP TgCRND8 mice. Genes Brain Behav (2009) 0.84
Entorhinal cortex contributes to object-in-place scene memory. Eur J Neurosci (2004) 0.83
Loss of high-level perceptual knowledge of object structure in DAT. Neuropsychologia (2005) 0.82
Object recognition memory and cholinergic parameters in mice expressing human presenilin 1 transgenes. Exp Neurol (2002) 0.80
Visual recognition memory in Alzheimer's disease: repetition-lag effects. Exp Aging Res (2008) 0.77
Involvement of GABAergic mechanisms in the optokinetic nystagmus of the frog. Exp Brain Res (1983) 0.77
Directional asymmetry of the horizontal monocular head and eye optokinetic nystagmus: effects of picrotoxin. Vision Res (1990) 0.76
Hippocampal response to visual objects is related to visual memory functioning. Neuroreport (2008) 0.76
Computational and experimental identification of C. elegans microRNAs. Mol Cell (2003) 5.22
Deintensification candidate subgroups in human papillomavirus-related oropharyngeal cancer according to minimal risk of distant metastasis. J Clin Oncol (2013) 3.76
A recombinant Mycobacterium smegmatis induces potent bactericidal immunity against Mycobacterium tuberculosis. Nat Med (2011) 3.60
Kindling and status epilepticus models of epilepsy: rewiring the brain. Prog Neurobiol (2004) 2.91
Long-term outcomes by clopidogrel duration and stent type in a diabetic population with de novo coronary artery lesions. J Am Coll Cardiol (2008) 2.90
Comparative prognostic value of HPV16 E6 mRNA compared with in situ hybridization for human oropharyngeal squamous carcinoma. J Clin Oncol (2009) 2.74
Precursor form of brain-derived neurotrophic factor and mature brain-derived neurotrophic factor are decreased in the pre-clinical stages of Alzheimer's disease. J Neurochem (2005) 2.36
Cyclohexanehexol inhibitors of Abeta aggregation prevent and reverse Alzheimer phenotype in a mouse model. Nat Med (2006) 2.28
Recombinant pro-apoptotic Mycobacterium tuberculosis generates CD8+ T cell responses against human immunodeficiency virus type 1 Env and M. tuberculosis in neonatal mice. Vaccine (2009) 2.12
Addition of bevacizumab to standard chemoradiation for locoregionally advanced nasopharyngeal carcinoma (RTOG 0615): a phase 2 multi-institutional trial. Lancet Oncol (2011) 2.03
Ciliary body lymphangiogenesis in uveal melanoma with and without extraocular extension. Ophthalmology (2012) 2.03
Ultrasound biomicroscopy of the ciliary body in ocular/oculodermal melanocytosis. Am J Ophthalmol (2012) 2.01
A comparison of risk perception and psychological morbidity in women with ductal carcinoma in situ and early invasive breast cancer. Breast Cancer Res Treat (2003) 1.98
Stereotactic body radiotherapy for colorectal liver metastases: a pooled analysis. Cancer (2011) 1.87
Widespread cortical thinning is a robust anatomical marker for attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry (2009) 1.87
PTH and the risks for hip, vertebral, and pelvic fractures among patients on dialysis. Am J Kidney Dis (2006) 1.86
IMRT for adjuvant radiation in gastric cancer: a preferred plan? Int J Radiat Oncol Biol Phys (2005) 1.84
Selective targeting of perivascular macrophages for clearance of beta-amyloid in cerebral amyloid angiopathy. Proc Natl Acad Sci U S A (2009) 1.83
Glaucoma as a neurodegenerative disease. Curr Opin Ophthalmol (2007) 1.80
Alpha5GABAA receptors mediate the amnestic but not sedative-hypnotic effects of the general anesthetic etomidate. J Neurosci (2006) 1.70
Neuroprotection and lifespan extension in Ppt1(-/-) mice by NtBuHA: therapeutic implications for INCL. Nat Neurosci (2013) 1.58
Long radiology workdays reduce detection and accommodation accuracy. J Am Coll Radiol (2010) 1.51
Identification of a small molecule with activity against drug-resistant and persistent tuberculosis. Proc Natl Acad Sci U S A (2013) 1.51
The CNS glycoprotein Shadoo has PrP(C)-like protective properties and displays reduced levels in prion infections. EMBO J (2007) 1.49
Atypical clinical behavior of p16-confirmed HPV-related oropharyngeal squamous cell carcinoma treated with radical radiotherapy. Int J Radiat Oncol Biol Phys (2010) 1.49
Increased proNGF levels in subjects with mild cognitive impairment and mild Alzheimer disease. J Neuropathol Exp Neurol (2004) 1.48
Proteasome inhibition by fellutamide B induces nerve growth factor synthesis. Chem Biol (2008) 1.45
Natural course of distant metastases following radiotherapy or chemoradiotherapy in HPV-related oropharyngeal cancer. Oral Oncol (2012) 1.38
Rhinoplasty with advancing age. Plast Reconstr Surg (2004) 1.37
A 2-year-old boy with knee pain, fever, and multiple birthmarks. Clin Pediatr (Phila) (2014) 1.37
Differential gene expression profiling of short and long term denervated muscle. FASEB J (2005) 1.36
APH-1 interacts with mature and immature forms of presenilins and nicastrin and may play a role in maturation of presenilin.nicastrin complexes. J Biol Chem (2002) 1.34
The nerve growth factor precursor proNGF exhibits neurotrophic activity but is less active than mature nerve growth factor. J Neurochem (2004) 1.34
Oligomeric amyloid decreases basal levels of brain-derived neurotrophic factor (BDNF) mRNA via specific downregulation of BDNF transcripts IV and V in differentiated human neuroblastoma cells. J Neurosci (2007) 1.30
Interactions between beta-amyloid and central cholinergic neurons: implications for Alzheimer's disease. J Psychiatry Neurosci (2004) 1.30
Mature glycosylation and trafficking of nicastrin modulate its binding to presenilins. J Biol Chem (2002) 1.26
Auto-segmentation of normal and target structures in head and neck CT images: a feature-driven model-based approach. Med Phys (2011) 1.24
Genetic mapping of activity determinants within cellular prion proteins: N-terminal modules in PrPC offset pro-apoptotic activity of the Doppel helix B/B' region. J Biol Chem (2004) 1.23
Biological activity of nerve growth factor precursor is dependent upon relative levels of its receptors. J Biol Chem (2009) 1.21
Intraobserver and interobserver variability in GTV delineation on FDG-PET-CT images of head and neck cancers. Int J Radiat Oncol Biol Phys (2007) 1.20
Transmission patterns of HIV and hepatitis C virus among networks of people who inject drugs. PLoS One (2011) 1.20
An innovative technique of vertebral body stapling for the treatment of patients with adolescent idiopathic scoliosis: a feasibility, safety, and utility study. Spine (Phila Pa 1976) (2003) 1.20
Amyloid-β plaque reduction, endogenous antibody delivery and glial activation by brain-targeted, transcranial focused ultrasound. Exp Neurol (2013) 1.19
Decreased brain-derived neurotrophic factor depends on amyloid aggregation state in transgenic mouse models of Alzheimer's disease. J Neurosci (2009) 1.19
A population-based approach to determine the prevalence of transmitted drug-resistant HIV among recent versus established HIV infections: results from the Canadian HIV strain and drug resistance surveillance program. J Acquir Immune Defic Syndr (2006) 1.19
Immunotherapy for Alzheimer's disease. Proc Natl Acad Sci U S A (2004) 1.17
Pro-brain-derived neurotrophic factor is decreased in parietal cortex in Alzheimer's disease. Brain Res Mol Brain Res (2003) 1.17
Pharmacokinetics of a ginseng saponin metabolite compound K in rats. Biopharm Drug Dispos (2006) 1.17
Dimerization of the transmembrane domain of amyloid precursor proteins and familial Alzheimer's disease mutants. BMC Neurosci (2008) 1.17
Chronic ocular hypertension induces dendrite pathology in the lateral geniculate nucleus of the brain. Exp Eye Res (2006) 1.16
Outcomes of HPV-related oropharyngeal cancer patients treated by radiotherapy alone using altered fractionation. Radiother Oncol (2012) 1.12
Externalizing and attentional behaviors in children of depressed mothers treated with a selective serotonin reuptake inhibitor antidepressant during pregnancy. Arch Pediatr Adolesc Med (2007) 1.12
Combined-modality treatment of solid tumors using radiotherapy and molecular targeted agents. J Clin Oncol (2003) 1.11
Inter- and intrafraction variability in liver position in non-breath-hold stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys (2009) 1.11
Risk of hospitalization for neutropenic complications of chemotherapy in patients with primary solid tumors receiving pegfilgrastim or filgrastim prophylaxis: a retrospective cohort study. Clin Ther (2009) 1.10
Validity, reliability, and responsiveness of the Kansas City Cardiomyopathy Questionnaire in anemic heart failure patients. Qual Life Res (2007) 1.09
Interfraction and respiratory organ motion during conformal radiotherapy in gastric cancer. Int J Radiat Oncol Biol Phys (2009) 1.09
Mania-like behavior induced by genetic dysfunction of the neuron-specific Na+,K+-ATPase α3 sodium pump. Proc Natl Acad Sci U S A (2011) 1.08
Genetic diversity as a marker for timing infection in HIV-infected patients: evaluation of a 6-month window and comparison with BED. J Infect Dis (2012) 1.08
Amyloid-beta fibrillogenesis: structural insight and therapeutic intervention. Exp Neurol (2009) 1.05
Multiple dysregulated pathways in nasopharyngeal carcinoma revealed by gene expression profiling. Int J Cancer (2006) 1.04
Interfraction and intrafraction changes in amplitude of breathing motion in stereotactic liver radiotherapy. Int J Radiat Oncol Biol Phys (2010) 1.03
Patterns of care in elderly head-and-neck cancer radiation oncology patients: a single-center cohort study. Int J Radiat Oncol Biol Phys (2010) 1.03
Retinal tau pathology in human glaucomas. Can J Ophthalmol (2008) 1.02
Interaction of human and mouse Abeta peptides. J Neurochem (2004) 1.01
Targeting of monomer/misfolded SOD1 as a therapeutic strategy for amyotrophic lateral sclerosis. J Neurosci (2012) 1.00
Conformal radiotherapy in the adjuvant treatment of gastric cancer: Review of 82 cases. Int J Radiat Oncol Biol Phys (2006) 1.00
Cholinotrophic molecular substrates of mild cognitive impairment in the elderly. Curr Alzheimer Res (2007) 1.00
Preoperative radiation with concurrent chemotherapy for resectable rectal cancer: effect of dose escalation on pathologic complete response, local recurrence-free survival, disease-free survival, and overall survival. Int J Radiat Oncol Biol Phys (2005) 1.00
Prognostic value of pretreatment circulating neutrophils, monocytes, and lymphocytes in oropharyngeal cancer stratified by human papillomavirus status. Cancer (2014) 0.99
NGF, BDNF, NT-3, and GDNF mRNA expression in rat skeletal muscle following denervation and sensory protection. J Neurotrauma (2004) 0.99
Contribution of simple saccharides to the stabilization of amyloid structure. Biochem Biophys Res Commun (2005) 0.99
Glutathione and infection. Biochim Biophys Acta (2012) 0.99
A new brain-derived neurotrophic factor transcript and decrease in brain-derived neurotrophic factor transcripts 1, 2 and 3 in Alzheimer's disease parietal cortex. J Neurochem (2002) 0.99
BDNF increases with behavioral enrichment and an antioxidant diet in the aged dog. Neurobiol Aging (2010) 0.99
Ferumoxtran-10-enhanced MR lymphangiography: does contrast-enhanced imaging alone suffice for accurate lymph node characterization? AJR Am J Roentgenol (2006) 0.98
Tolerability of the Intergroup 0099 (INT 0099) regimen in locally advanced nasopharyngeal cancer with a focus on patients' nutritional status. Int J Radiat Oncol Biol Phys (2004) 0.98
Integrity and regeneration of mechanotransduction machinery regulate aminoglycoside entry and sensory cell death. PLoS One (2013) 0.97
Disruption of adaptive energy metabolism and elevated ribosomal p-S6K1 levels contribute to INCL pathogenesis: partial rescue by resveratrol. Hum Mol Genet (2010) 0.97
Perineural invasion and spread in head and neck cancer. Expert Rev Anticancer Ther (2012) 0.97
What changes can we expect in the brain of glaucoma patients? Surv Ophthalmol (2007) 0.97
Immunotherapy as treatment for Alzheimer's disease. Expert Rev Neurother (2007) 0.97
The blood-brain barrier is disrupted in a mouse model of infantile neuronal ceroid lipofuscinosis: amelioration by resveratrol. Hum Mol Genet (2012) 0.97
Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ ? Breast Cancer Res Treat (2004) 0.96
Circumferential viscocanalostomy and suture canal distension (canaloplasty) for whites with open-angle glaucoma. J Glaucoma (2011) 0.96
Age-dependent impairment of spine morphology and synaptic plasticity in hippocampal CA1 neurons of a presenilin 1 transgenic mouse model of Alzheimer's disease. J Neurosci (2009) 0.95
The low density lipoprotein receptor is not necessary for maintaining mouse brain polyunsaturated fatty acid concentrations. J Lipid Res (2007) 0.95
Small molecule beta-amyloid inhibitors that stabilize protofibrillar structures in vitro improve cognition and pathology in a mouse model of Alzheimer's disease. Eur J Neurosci (2010) 0.95
Contribution of the distal nerve sheath to nerve and muscle preservation following denervation and sensory protection. J Reconstr Microsurg (2005) 0.94
Quantum dots trace lymphatic drainage from the mouse eye. Nanotechnology (2011) 0.94
Dynamic palmitoylation links cytosol-membrane shuttling of acyl-protein thioesterase-1 and acyl-protein thioesterase-2 with that of proto-oncogene H-ras product and growth-associated protein-43. J Biol Chem (2013) 0.93
Pelvic MRI in children with Crohn disease and suspected perianal involvement. Pediatr Radiol (2006) 0.93
Clearance of amyloid-β peptides by microglia and macrophages: the issue of what, when and where. Future Neurol (2012) 0.93
Altered balance of proteolytic isoforms of pro-brain-derived neurotrophic factor in autism. J Neuropathol Exp Neurol (2012) 0.92
TgCRND8 amyloid precursor protein transgenic mice exhibit an altered gamma-secretase processing and an aggressive, additive amyloid pathology subject to immunotherapeutic modulation. Biochemistry (2007) 0.92
Clinical application of sensory protection of denervated muscle. J Neurosurg (2008) 0.92